Study Design. A retrospective study. Objective. The aim of this study was to discuss the factors that may affect surgical outcomes of patient with diffuse large B-cell lymphoma (DLBCL)-associated metastatic spinal cord compression (MSCC). Summary of Background Data. DLBCL in the spine is rare and minimal information has been published in the literature regarding this subject. Although DLBCL is highly sensitive to both chemotherapy and radiotherapy, surgical decompression is recommended in the treatment of DLBCL-associated MSCC. However, the prognostic factors affecting surgical outcomes of patients with DLBCL-associated MSCC remain unknown. Methods. We conducted a retrospective study to investigate the impact of surgical decompression on recovery from neurological deficit caused by DLBCL-associated MSCC. Univariate and multivariate analyses were performed to identify prognostic factors for overall survival of spinal DLBCL. The survival rate was estimated by the Kaplan-Meier method, and differences were analyzed by the log-rank test. Factors with P values of 0.1 or less were subjected to multivariate analysis for survival rate by multivariate Cox proportional hazards analysis. Results. A total of 37 patients with spinal DLBCL from 2003 to 2014 were included in the study. International Prognostic Index (IPI) (0-1/2-5), duration of preoperative symptoms ( 2m/>2m), and lactate dehydrogenase (normal/abnormal) were suggested as the potential prognostic factors through univariate analysis. However, as they were submitted to the multivariate Cox regression model, only IPI and duration of preoperative symptoms were found as independent prognostic factors. Conclusion. Surgical decompression improves recovery from neurological deficit. Patient IPI score plays an important role in decision making for surgical intervention, as it affects the length of survival and functional outcome. Patients with duration of preoperative symptoms no more than 2 months confer a very poor prognosis.
P rimary non-Hodgkin lymphoma (PNHL) of the bone is a rare disease that is often referred to as primary lymphoma of bone. 1 The PNHL of the spine (PNHLS) varies from 6% to 32% of all primary nonHodgkin bone lymphoma (PBL). 2, 3 Patients with PNHLS often presented neurological complications because of metastatic spinal cord compression (MSCC). The use of recent advances in surgical decompression of the metastatic lesion with spinal instrumentation has resulted in great improvement in the outcome of solid malignancies. 4 According to the World Health Organization classification, diffuse large B-cell lymphoma (DLBCL) is the most common diagnosis of PNHLS. However, the optimal treatment for PNHLS associated with MSCC has been controversial. Like most of hematological malignancies, DLBCL is highly sensitive to chemotherapy and radiotherapy. 5 As DLBCL usually responds to chemotherapy within days, chemotherapy may be able to replace decompression surgery in DLBCL patients who have MSCC. Radiotherapy is another effective alternative treatment for patients with localized DLBCL of the spine. Peng et al. 6 showed a negative impact of decompression surgery on survival in patients with PNHLS with MSCC. However, the study conducted by Ching-Ming Chang and his colleagues demonstrated that surgical decompression improves recovery from neurological deficit and may potentially provide a survival benefit in patients with DLBCL-associated MSCC. 7 Both of the studies lack statistical power; whether surgical decompression can benefit patients with DLBCL-associated MSCC remains unclear.
Given this background, here we present 37 consecutive patients with MSCC caused by DLBCL in our center between 2003 and 2014, who were treated by tumor resection and spine reconstruction. The purpose of the present study was to evaluate the surgical outcomes and prognostic factors on such condition. To the best of our knowledge, this is the largest case series on this subject reported in recent years.
MATERIALS AND METHODS
We performed a retrospective review of patients treated in Changzheng Hospital, Shanghai of China, over a period of 11 years (2003-2014) . The clinical and operative notes, radiographic images, and pathological reports of all patients who received surgery in our department for DLBCL-associated MSCC were reviewed. Positron emission tomography-computed tomography (PET-CT) was recommended when patients suspicious of spine tumor presented with spinal cord compression as the first symptom. The diagnosis of DLBCL was reconfirmed by a pathologist according to the 2008 WHO classification of lymphomas. 8 The DLBCL patients with MSCC were evaluated using the Ann-Arbor staging system. 9 All patients presented with MSCC as the first symptom. The major clinical characteristics comprised numbness, lower or upper limb weakness, and sphincter function dysfunction. We evaluated the impairment of spinal compression according to the American Spinal Injury Association impairment scale (ASIAS). 10 Each patient was assigned an International Prognostic Index (IPI) score. 11 The Eastern Cooperative Oncology Group (ECOG) scale was used to assess performance status. 12 All cases in our study matched at least one of the following conditions: spinal instability, confirmed DLBCL diagnosis but poorly responding to chemotherapy, and uncertain pathological diagnosis after needle biopsy or unsuitable for needle biopsy due to awkward tumor location (confirmed according to postoperative specimen) with rapid deterioration of neurological function. All patients received surgical decompression and stabilization by three senior consultant spinal surgeons promptly after diagnosis for MSCC. This included stabilization using a posterior approach, an anterior approach, or both. No patient deteriorated neurologically in the immediate postoperative period. Patients who had biopsy alone or cement augmentation without stabilization were not included.
Statistical Analysis
Quantitative data are described by median (range), and qualitative data are described as counts and percentages. Overall survival (OS) was measured from the time of diagnosis to the date of the last follow-up or death from any causes. Survival curves were constructed according to the Kaplan-Meier method and comparison was conducted by using the log-rank test. The univariate and multivariate analyses of various clinical factors were performed to identify independent variables that could predict prognosis. Factors with P values of 0.1 or less were subjected to multivariate analysis for survival rate by multivariate Cox proportional hazards analysis. P values of less than 0.05 were considered statistically significant. All statistical calculations were performed by PASW Statistics, version 19.0 (IBM Corp., New York, NY).
RESULTS

Patient Descriptions
Our cohort consisted of 37 patients, 14 (38%) women and 23 (62%) men, with MSCC caused by DLBCL and were admitted to our spine center. The mean age was 46.1 years (range 18-77 yrs). The median follow-up of this study was 37.9 months (range: 1.63-101.7 mnths).
Tumor lesions involved the cervical spine in five (13.5%) cases, thoracic spine in 18 (48.6%) cases, lumbar spine in 10 (27.0%) cases, and sacrum in four (10.8%) cases. The relationship between clinical symptoms and spine level is listed in Table 1 .
The major clinical characteristics comprised numbness in 15 (40%) cases, lower or upper limb weakness in 30 (81%) cases, and sphincter function dysfunction in 16 (43%) cases. All patients (100%) suffered severe pain within areas of the neck, shoulders, backside, or limbs. The mean duration of symptoms was 3.5 months (range: 1 d-2 yrs). Acute neurological deficit was presented in eight patients.
Patient Neurological Evaluation, Staging, IPI, and Multidisciplinary Treatment
According to the ASIAS, there were five cases of Grade A, one case of Grade B, nine cases of Grade C, and 22 cases of Grade D. On the basis of the ECOG scales, there were seven cases in ECOG 1, 13 cases in ECOG 2, five cases in ECOG 3, and 12 cases in ECOG 4.
Patients recovered from their neurological deficit at different levels after decompression. According to the postoperative ASIAS, there were 28 cases in Grade E, four cases of Grade D, three cases of Grade C, two cases of Grade A. In particular, one male patient (Patient #7) had a completely recovery from ASIAS grade A.
On the basis of the Ann-Arbor staging system, only one patient was classified into stage II, nine patients were classified into stage III, whereas the other patients were classified into stage IV. B symptom (fever, night sweats, and weight loss), which is a typical presentation of NHL, appeared in 10 of 37 patients (27.3%).
Regarding the IPI classification, 21 patients in our cohort were in a high-intermediate or high-risk group, and 16 of them were in a low or low-intermediate risk group.
Thirty-three patients (91.9%) received six to eight cycles of chemotherapy after surgery except four, who died within four months after the surgery. For 19 of the 33 patients, chemotherapy consisted of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). In the remaining patients, three received CHOP along with rituximab (R-CHOP). All patients received intraoperative local chemotherapy with cisplatin for local control.
Sixteen patients (43.2%) who underwent local radiotherapy focused on the involved segments. The total doses of radiotherapy ranged from 40 to 55 Gy, with a median dose of 50 Gy. The remaining patients did not receive radiotherapy, four for the poor general condition and the others for individual refusal.
Univariate Analysis of Prognostic Factors
The univariate analysis of the prognostic factors affecting survival time is summarized in Table 2 . The OS at 5 years was 59.0% (AE9%). According to statistical analysis, patients with duration of preoperative symptoms no more than 2 months had a worse survival than those with that more than 2 months (P < 0.001). Patients with a normal lactate dehydrogenase (LDH) level had a better survival than those with an elevated LDH level (P ¼ 0.004). Patients in low IPI groups (0-1) had a better survival than those in high IPI groups (2-5) (P ¼ 0.003). However, there was no statistical difference in survival between patients underwent R-CHOP chemotherapy and those underwent CHOP chemotherapy (P ¼ 0.278). Neither was there a statistical difference between patients who had radiotherapy after surgery and those who did not (P ¼ 0.817). Among the other possible prognostic factors, no significant difference was found in age, gender, performance status, B symptom, extranodal involvement, Ann Arbor Stage, means albumin, means erythrocyte sedimentation rate, and means alkaline phosphatase.
Multivariate Analysis of Prognostic Factors
Univariate analysis suggested that the potential prognostic factors were IPI (0-1/ 2-5), LDH ( 245/ >245), and incubation ( 2 m/>2 m). These factors were submitted to the multivariate Cox regression model for analysis of OS. The risk of death from disease was significantly decreased in patients in low IPI groups (0-1) compared with patients in high IPI groups (2-5). The hazard ratio was 4.882 (95% confidence interval: 1.320-18.058) for survival (P ¼ 0.018). On the contrary, patients with preoperative symptoms duration no more than 2 months had a worse survival than those with that more than 2 months. The hazard ratio was 0.174 (95% confidence interval: 0.040-0.765) for survival (P ¼ 0.021). The Kaplan-Meier curves of survival for IPI and Incubation are shown in Figures 1 and 2 . The result of multivariate analysis showed that LDH was not the independent prognostic factor for OS. Details are listed in Table 3 . Whether to perform surgery for patients with DLBCLassociated MSCC is always controversial. The data on the treatment of PNHLS are filled with contradiction. Peng et al. 6 suggested that the combination of chemotherapy and radiotherapy was able to rapidly reduce spinal cord and nerve root compression due to intraspinal soft tissue extension. This view was supported by Charles-Henri et al. 15 ; they treated patients with MSCC due to hematological malignancies and found that chemotherapy shrinked the epidural tumor volume from 3.9 to 0.22 cm 3 (P ¼ 0.007). However, the conclusion is established on the basis of a confirmed DLBCL diagnosis. Current imaging technology could not clearly differentiate NHL from other cancers. 16 The needle biopsy played an important role in early diagnosis, but the satisfying positive rate of needle biopsy was hard to achieve. DLBCL is a malignancy with rapid tumor proliferation; spinal cord compression may occur within weeks of the onset of MSCC. The neurologic function of patient may be hard to recover without decompression of spinal cord in time. Chang et al. 7 reported that the rates of complete recovery from neurological deficit were 100% for patients with DLBCL in the surgical group, but only 20% in nonsurgical group (P ¼ 0.015). Tang et al. 5 suggested that if patients had severe spinal cord compression (muscle strength: Grade < 3) due to primary lesion, surgical intervention should be conducted immediately regardless of what caused the compression. In our study, there are 13 patients who failed to achieve needle biopsy because of the awkward location of tumor. After a discussion with the patients and their families, they were operated on. We suggested that patients with DLBCL-associated MSCC may merit a spinal decompression, not a biopsy alone in the absence of known malignancy sometimes. The study from McDonald et al. 17 shared the same point of view.
Patients with DLBCL had 5-and 10-year OS of 62% and 41%, respectively.
3 Our result tallies with previous studies. The 1-and 3-years survival rates were 78% and 69%, respectively. These results may suggest that the presence of pathological fracture or spinal cord compression may not impact the OS. Dubey et al. 18 showed the value of IPI, the same prognostic index used in nodal non-Hodgkin lymphoma, in PBL. 13 According to the univariate analysis, we found that patients with a normal LDH had a significantly longer survival than those with above-normal LDH. Patients with IPI values higher than 1 at diagnosis have been associated with a worse prognosis. However, only IPI confirmed its prognostic value when these two factors were submitted to the multivariate Cox regression model. One possible reason for this result is LDH, which is an important element of IPI. 19 Another interesting finding that emerged from our study is patients with duration of preoperative symptoms no more than 2 months were found to be associated with a poorer outcome. DLBCL is a rapid progressive disease. Generally speaking, early appearance of neurological deficit means more malignant tumor. There may be some genetic deficit in patients with early MSCC symptoms, which may cause resistant to chemotherapy and radiation. 20 That may explain why patients with neurological deficit shorter than 2 months lived shorter than those with neurological deficit longer than 2 months.
Most of our patients received chemotherapy except those who survived less than 4 months. Chemotherapy is the most important method to treat lymphoma. Some clinicians thought that chemotherapy along with radiation had significantly better OS than patients treated with chemotherapy or radiation alone for localized PBL. The introduction of rituximab had an obvious effect on CD20 antigen positive DLBCL patients. [21] [22] [23] In our series, the R-CHOP protocol did not show significant difference from the standard CHOP protocols. However, this may be due to the small study cohort and its retrospective nature. Radiation was performed in 16 patients to prevent local recurrence. The patients were treated with a median dose of 50 Gy. No relapses of surgical sites were observed in the follow-up. But unfortunately, the clinical results in this series indicate that there were no differences in OS between radiotherapy group and nonradiotherapy group. However, this result must be cautiously interpreted because the decision to use irradiation was individualized. It is possible that patients with more biologically aggressive disease were more likely to receive irradiation, obscuring its impact.
CONCLUSION
The combination of chemotherapy and radiotherapy is effective to manage DLBCL-associated MSCC. However, surgical treatment must be considered in case of acute vertebral collapse, or if the diagnosis is uncertain and a biopsy is needed, or if the neurological symptoms deteriorate under medical treatment. Previous analyses showed that there was no evidence of difference in OS relative to the involvement of axial skeleton and relative to the involvement of extremities. Therefore, the fundamental goal of the treatment was to improve the patient's quality of life as much as possible. Our results have demonstrated that surgical decompression improves recovery from neurological deficit. Patient IPI score plays an important role in making decision for surgical intervention, as it affects the length of survival and functional outcome. Patients with duration of preoperative symptoms no more than 2 months confer a very poor prognosis.
Key Points
Surgical decompression could improve recovery from neurological deficit in patients with DLBCLassociated MSCC. Prognostic index score plays an important role in decision making for surgical intervention, as it affects the length of survival and functional outcome. Patients with duration of preoperative symptoms no more than 2 months confer a very poor prognosis.
